Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

ANTIPAR FILM COATED TABLET 150 mg/37.5 mg/200 mg - HSA Drug Approval Details

Approvals/HSA/ANTIPAR FILM COATED TABLET 150 mg/37.5 mg/200 mg

Approved

THERAPEUTIC

ANTIPAR FILM COATED TABLET 150 mg/37.5 mg/200 mg

İlko İlaç Sanayi ve Ticaret A. Ş.🇸🇬 Health Sciences Authority

Approval Date: Feb 20, 2024
Approval ID: b0a7cc5363ad61a0
Company: İlko İlaç Sanayi ve Ticaret A. Ş.
Type: Therapeutic

Approval Details

Approval Id: b0a7cc5363ad61a0
Drug Name: ANTIPAR FILM COATED TABLET 150 mg/37.5 mg/200 mg
Product Name: ANTIPAR FILM COATED TABLET 150 mg/37.5 mg/200 mg
Approval Number: SIN16957P
Approval Date: 2024-02-20
Registrant: GOLDPLUS UNIVERSAL PTE LTD
Drug Type: Therapeutic
Forensic Classification: Prescription Only
Dosage Form: TABLET, FILM COATED
Route Of Administration: ORAL
Atc Code: N04BA03
Atc Item Name: levodopa, decarboxylase inhibitor and COMT inhibitor
Pharma Manufacturer Name: GOLDPLUS UNIVERSAL PTE LTD
Company Detail Path: /organization/7cb5b69d6eb36564/goldplus-universal-pte-ltd

Active Ingredients

Carbidopa Monohydrate eqv Carbidopa

37.5mg

Entacapone

200.000mg

Levodopa

150.000mg

Carbidopa Monohydrate eqv Carbidopa

37.5mg

Entacapone

200.000mg

Levodopa

150.000mg

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Feb 20, 2024

Approval ID

b0a7cc5363ad61a0

Type

Therapeutic

Back to HSA Approvals